Search Results
Viewing: 771-780 of 11771 | All
Clinical Research Blog Library
The 700 Children's blog covers the most common topics, frequently asked questions and current pediatric health care information written by pediatric experts. Our team covers the latest from clinical study participation and beyond.
Speech and Language Pathology Clinical Research
Learn more about clinical research relating to speech and language pathology.
Safety and Injury Prevention Clinical Research
Learn more about clinical research relating to safety and injury prevention.
Article
CHTN Pediatric Division
The Cooperative Human Tissue Network (CHTN) facilitates access to human tissue for research, accelerating scientific discoveries in medical diagnoses and treatment. The Pediatric Division is managed by the Biopathology Center at Nationwide Children’s Hospital.
Article
About Us
The BCR at Nationwide Children's Hospital is composed of six primary workgroups: Client Services Logistics Histology Pathology and Virtual Microscopy Molecular Informatics This subdivision of workgroups creates a modular system which allows the BCR flexibility and variety in the functions it
Article
ALCHEMIST
The Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials, or ALCHEMIST, is a group of clinical trials for patients with certain types of early-stage non-small cell lung cancers (NSCLC) that have been treated surgically.
Article
Exceptional Responders
The National Cancer Institute (NCI) has embarked on the Exceptional Responders (ER) Initiative to understand the molecular underpinnings of exceptional responses to treatment, primarily via chemotherapy, in cancer patients.
Article
Burkitt Lymphoma Genome Sequencing Project
The BCR serves as the biospecimen processing core for the Burkitt Lymphoma Genome Sequencing Project (BLGSP). Burkitt lymphoma is a type of non-Hodgkin lymphoma that occurs most often in children and young adults.
Article
Clinical Trials Sequencing Project
The Clinical Trials Sequencing Project (CTSP) will promote the use of genomics to explain the molecular basis of response and resistance to therapies studied in National Cancer Institute (NCI)-sponsored clinical trials of the National Clinical Trials Network (NCTN).